Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Murray

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Clinical Therapeutics|June 6, 2022
Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate CombinationStanley B Cohen, Boulos Haraoui, Jeffrey R Curtis, et al.
Drug Discovery Today|March 18, 2019
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug designMarc O'Reilly, Anne Cleasby, Thomas G Davies, et al.
Journal of Chemical Information and Computer Sciences|May 25, 2004
Virtual screening using protein-ligand docking: avoiding artificial enrichmentMarcel L Verdonk, Valerio Berdini, Michael J Hartshorn, et al.
Journal of Medicinal Chemistry|February 16, 2007
Diverse, high-quality test set for the validation of protein-ligand docking performanceMichael J Hartshorn, Marcel L Verdonk, Gianni Chessari, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to beta-secretaseChristopher W Murray, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|September 30, 2005
Modeling water molecules in protein-ligand docking using GOLDMarcel L Verdonk, Gianni Chessari, Jason C Cole, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|February 17, 2006
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitorsNigel Howard, Chris Abell, Wendy Blakemore, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Modeling compound lipid homeostasis using stable isotope tracingKarl Wessendorf-Rodriguez, Maureen L Ruchhoeft, Ethan L Ashley, et al.
Cell Metabolism|February 21, 2026
Modeling lipid homeostasis using stable isotope tracing and flux analysisKarl Wessendorf-Rodriguez, Maureen L Ruchhoeft, Christopher W Murray, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|June 6, 2022
Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate CombinationStanley B Cohen, Boulos Haraoui, Jeffrey R Curtis, et al.
Drug Discovery Today|March 18, 2019
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug designMarc O'Reilly, Anne Cleasby, Thomas G Davies, et al.
Journal of Chemical Information and Computer Sciences|May 25, 2004
Virtual screening using protein-ligand docking: avoiding artificial enrichmentMarcel L Verdonk, Valerio Berdini, Michael J Hartshorn, et al.
Journal of Medicinal Chemistry|February 16, 2007
Diverse, high-quality test set for the validation of protein-ligand docking performanceMichael J Hartshorn, Marcel L Verdonk, Gianni Chessari, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to beta-secretaseChristopher W Murray, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|September 30, 2005
Modeling water molecules in protein-ligand docking using GOLDMarcel L Verdonk, Gianni Chessari, Jason C Cole, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|February 17, 2006
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitorsNigel Howard, Chris Abell, Wendy Blakemore, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Modeling compound lipid homeostasis using stable isotope tracingKarl Wessendorf-Rodriguez, Maureen L Ruchhoeft, Ethan L Ashley, et al.
Cell Metabolism|February 21, 2026
Modeling lipid homeostasis using stable isotope tracing and flux analysisKarl Wessendorf-Rodriguez, Maureen L Ruchhoeft, Christopher W Murray, et al.
Pageof 7